Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess comparative performance of 14 hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B (CHB) patients using on-treatment values at different timepoints.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am J Gastroenterol

Title: The American journal of gastroenterology

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1572-0241

ISSN (Print): 0002-9270

Publication date (Electronic): Sep 01 2022

Volume: 117

Issue: 9

Affiliations

[1 ] National Clinical Research Center of Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, Mainland China.

[2 ] Liver Research Center, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing Friendship Hospital, Capital Medical University, Beijing, Mainland China.

[3 ] Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, Mainland China.

[4 ] Genomics Research Center, Academia Sinica, Taipei, Taiwan.

[5 ] Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

[6 ] Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

[7 ] Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan.

Article

Publisher Item ID: 00000434-202209000-00020

DOI: 10.14309/ajg.0000000000001865

PubMed ID: 35973147

SO-VID: a68db5eb-a97b-4957-94cb-f5700d7e89b4

History

Data availability:

Comments

Comment on this article

Cited by 4

See all cited by